Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies

NCT00381654 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Study did not meet pre-specified objectives.

Conditions

Tumor

Interventions

DRUG: AV-412

Sponsor

AVEO Pharmaceuticals, Inc.